CN1868422A - 修复皮肤缺损的人工皮肤的制备方法 - Google Patents
修复皮肤缺损的人工皮肤的制备方法 Download PDFInfo
- Publication number
- CN1868422A CN1868422A CNA2005100427192A CN200510042719A CN1868422A CN 1868422 A CN1868422 A CN 1868422A CN A2005100427192 A CNA2005100427192 A CN A2005100427192A CN 200510042719 A CN200510042719 A CN 200510042719A CN 1868422 A CN1868422 A CN 1868422A
- Authority
- CN
- China
- Prior art keywords
- artificial skin
- skin
- preparation
- culture fluid
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000007547 defect Effects 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 15
- 239000011159 matrix material Substances 0.000 claims abstract description 18
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 210000001339 epidermal cell Anatomy 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 44
- 239000012531 culture fluid Substances 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 36
- 239000012528 membrane Substances 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 9
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 9
- 239000001110 calcium chloride Substances 0.000 claims description 9
- 230000003203 everyday effect Effects 0.000 claims description 9
- 238000000338 in vitro Methods 0.000 claims description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 239000002211 L-ascorbic acid Substances 0.000 claims description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 5
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 5
- 229940116977 epidermal growth factor Drugs 0.000 claims description 5
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 5
- 230000003780 keratinization Effects 0.000 claims description 4
- 230000035800 maturation Effects 0.000 claims description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
- 229930024421 Adenine Natural products 0.000 claims description 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 3
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 102000002070 Transferrins Human genes 0.000 claims description 3
- 108010015865 Transferrins Proteins 0.000 claims description 3
- 229960000643 adenine Drugs 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229960000890 hydrocortisone Drugs 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000000053 physical method Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000020774 essential nutrients Nutrition 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 abstract description 7
- 231100000397 ulcer Toxicity 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 238000012258 culturing Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 116
- 210000002615 epidermis Anatomy 0.000 description 22
- 210000001519 tissue Anatomy 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 210000004379 membrane Anatomy 0.000 description 9
- 230000029087 digestion Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 4
- 208000028990 Skin injury Diseases 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 102000002734 Collagen Type VI Human genes 0.000 description 3
- 108010043741 Collagen Type VI Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000515 collagen sponge Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000000642 iatrogenic effect Effects 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 206010058820 Acantholysis Diseases 0.000 description 2
- 206010056340 Diabetic ulcer Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 210000001047 desmosome Anatomy 0.000 description 2
- 230000003328 fibroblastic effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 108010001781 Apligraf Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014989 Epidermolysis bullosa Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001665 muscle stem cell Anatomy 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- -1 pellosil Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
成份 | 最终浓度 |
商用最低必需培养液(DMEM)商用培养液F12胎牛血清胰岛素氢化可的松碱性成纤维细胞生长因子转铁蛋白腺嘌呤抗生素 | 60-70%20-25%5-15%1-50ng/ml100-900ng/ml0.1ng-10ng/ml1-10mg/ml0.02-0.20mM200-2000i.u/ml |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100427192A CN100462059C (zh) | 2005-05-25 | 2005-05-25 | 修复皮肤缺损的人工皮肤的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100427192A CN100462059C (zh) | 2005-05-25 | 2005-05-25 | 修复皮肤缺损的人工皮肤的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1868422A true CN1868422A (zh) | 2006-11-29 |
CN100462059C CN100462059C (zh) | 2009-02-18 |
Family
ID=37442292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100427192A Expired - Fee Related CN100462059C (zh) | 2005-05-25 | 2005-05-25 | 修复皮肤缺损的人工皮肤的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100462059C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361989B (zh) * | 2008-09-03 | 2012-09-19 | 陕西瑞盛生物科技有限公司 | 双层膜状组织修补材料及其制备方法 |
CN103736150A (zh) * | 2013-12-31 | 2014-04-23 | 中山大学 | 褪黑素协同细胞外基质生物材料在制备促进间充质干细胞成骨分化药物中的应用 |
CN104068945A (zh) * | 2014-06-27 | 2014-10-01 | 深圳齐康医疗器械有限公司 | 一种人工皮肤及其制备方法 |
CN107287152A (zh) * | 2017-06-18 | 2017-10-24 | 广东博溪生物科技有限公司 | 用于化妆品抗衰检测的双层皮肤模型的构建方法及培养液 |
CN110923193A (zh) * | 2015-07-29 | 2020-03-27 | 广东博与再生医学有限公司 | 皮肤溃疡修复基质用培养基的配制方法 |
CN111450321A (zh) * | 2019-01-18 | 2020-07-28 | 北京华弗生物科技有限公司 | 人工皮肤替代物及其无支架自组装构建方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733530B1 (en) * | 1999-08-02 | 2004-05-11 | Eric Sun-Yin Chan | Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin |
CN1148230C (zh) * | 2001-02-06 | 2004-05-05 | 中国人民解放军第三军医大学第三附属医院 | 复合人工皮肤的制备方法 |
CN1415384A (zh) * | 2002-09-02 | 2003-05-07 | 中国人民解放军第四军医大学口腔医学院 | 组织工程全层皮肤的制备方法 |
CN1607012A (zh) * | 2003-10-13 | 2005-04-20 | 刘凯 | 人体组织工程皮肤的制备方法 |
-
2005
- 2005-05-25 CN CNB2005100427192A patent/CN100462059C/zh not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361989B (zh) * | 2008-09-03 | 2012-09-19 | 陕西瑞盛生物科技有限公司 | 双层膜状组织修补材料及其制备方法 |
CN103736150A (zh) * | 2013-12-31 | 2014-04-23 | 中山大学 | 褪黑素协同细胞外基质生物材料在制备促进间充质干细胞成骨分化药物中的应用 |
CN103736150B (zh) * | 2013-12-31 | 2015-11-18 | 中山大学 | 褪黑素协同细胞外基质生物材料在制备促进间充质干细胞成骨分化药物中的应用 |
CN104068945A (zh) * | 2014-06-27 | 2014-10-01 | 深圳齐康医疗器械有限公司 | 一种人工皮肤及其制备方法 |
CN104068945B (zh) * | 2014-06-27 | 2016-11-16 | 深圳齐康医疗器械有限公司 | 一种人工皮肤及其制备方法 |
CN110923193A (zh) * | 2015-07-29 | 2020-03-27 | 广东博与再生医学有限公司 | 皮肤溃疡修复基质用培养基的配制方法 |
CN107287152A (zh) * | 2017-06-18 | 2017-10-24 | 广东博溪生物科技有限公司 | 用于化妆品抗衰检测的双层皮肤模型的构建方法及培养液 |
CN107287152B (zh) * | 2017-06-18 | 2021-03-19 | 广东博溪生物科技有限公司 | 用于化妆品抗衰检测的双层皮肤模型的构建方法及培养液 |
CN111450321A (zh) * | 2019-01-18 | 2020-07-28 | 北京华弗生物科技有限公司 | 人工皮肤替代物及其无支架自组装构建方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100462059C (zh) | 2009-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Perng et al. | In vivo angiogenesis effect of porous collagen scaffold with hyaluronic acid oligosaccharides | |
US20110150846A1 (en) | Compositions and methods for tissue filling and regeneration | |
CN107988158B (zh) | 一种三维肿瘤模型脱细胞多孔支架、构建方法及其应用 | |
CN101147810B (zh) | 细胞-生物可降解材料复合物及其制备方法和应用 | |
CN110975011B (zh) | 一种皮肤溃疡修复基质的制备方法 | |
CN1800372A (zh) | 组织工程化细胞外基质的制备方法 | |
CN101775366A (zh) | 一种含毛囊组织工程皮肤的制备方法 | |
CN100462059C (zh) | 修复皮肤缺损的人工皮肤的制备方法 | |
CN101053679A (zh) | 一种纤维蛋白凝胶填充的聚合物多孔支架的制备方法 | |
CN110772669A (zh) | 一种用于3d打印人工皮肤的生物墨水 | |
CN101138654A (zh) | 含有外周血干细胞的组织工程皮肤及其制备方法 | |
CN114276567B (zh) | 一种用于组织工程皮肤构建的仿生水凝胶支架及其制备方法 | |
WO2018120672A1 (zh) | 一种诱导肌腱组织再生的生物活性支架及其制备方法和用途 | |
CN1232233C (zh) | 一种组织工程真皮的制备方法 | |
CN1148230C (zh) | 复合人工皮肤的制备方法 | |
CN101062429A (zh) | 一种组织工程化双层皮肤的构建方法与应用 | |
CN107890586B (zh) | 一种同种异体生物乳房补片的制备方法 | |
CN101138653B (zh) | 一种含脂肪层的组织工程皮肤及其制备方法 | |
CN101264337A (zh) | 一种胶原基生物医用材料的制备方法 | |
CN1887359A (zh) | 琼脂/胶原皮肤创伤修复敷料及其制备方法和应用 | |
KR20030093009A (ko) | 세포외기질을 포함하는 인공장기 제조용 생분해성 고분자기질 및 그의 제조방법 | |
CN101063109A (zh) | 一种可调节肤色的组织工程化皮肤的构建方法与应用 | |
CN1879578A (zh) | 一种具有生物活性的人工角膜的制备方法 | |
CN115850809B (zh) | 二硫化钼增强的巯基化透明质酸可注射水凝胶及其制备方法与应用 | |
CN1415384A (zh) | 组织工程全层皮肤的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHAANXI AIERFU BIOENGINEERING CO., LTD. Free format text: FORMER OWNER: STOMATOLOGICAL HOSPITAL, MILITARY SURGEON UNIV. NO.4, PLA Effective date: 20131128 Free format text: FORMER OWNER: SHAANXI AIERFU BIOENGINEERING CO., LTD. Effective date: 20131128 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: SHAANXI AIERFU ACTIVTISSUE ENGINEERING CO., LTD. Free format text: FORMER NAME: SHAANXI AIERFU BIOENGINEERING CO., LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710032 XI'AN, SHAANXI PROVINCE TO: 710065 XI'AN, SHAANXI PROVINCE |
|
CP03 | Change of name, title or address |
Address after: High tech Zone in Shaanxi province Xi'an gazelle road 710075 No. 4 Patentee after: SHAANXI AIERFU ACTIVTISSUE ENGINEERING Co.,Ltd. Address before: 710065 N306 room, 25 innovation building, Gaoxin hi tech Road, Shaanxi, Xi'an Patentee before: Shaanxi Elfu Bioengineering Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131128 Address after: 710065 N306 room, 25 innovation building, Gaoxin hi tech Road, Shaanxi, Xi'an Patentee after: Shaanxi Elfu Bioengineering Co.,Ltd. Address before: 710032 Shaanxi province Xi'an City Rehabilitation Road No. 7 Patentee before: Stomatological Hospital of the Fourth Military Medical University of Chinese PLA Patentee before: Shaanxi Elfu Bioengineering Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090218 Termination date: 20190525 |
|
CF01 | Termination of patent right due to non-payment of annual fee |